Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Evolutionary Changes Reproduced in the Lab by Manipulating Embryonic Development of Mice

By BiotechDaily International staff writers
Posted on 18 Aug 2014
Researchers have been able experimentally to reproduce in mice morphologic alterations that have taken millions of years to occur. Through small and gradual modifications in the embryonic development of mice teeth, produced in the laboratory, scientists have obtained teeth that morphologically are very similar to those observed in the fossil registry of rodent species that evolved from mice millions of years ago.

To modify the development of their teeth, the team from the Institute of Biotechnology of the University of Helsinki (Finland) worked with embryonic teeth cultures from mice not coded by the ectodysplasin A (EDA) protein, which regulates the formation of structures and differentiation of organs in the embryo throughout its development. The teeth obtained with these cultures which present this mutation develop into very fundamental forms, with very uniform crowns. Scientists gradually added different amounts of the EDA protein to the embryonic cells and let them develop.

The researchers observed that the teeth formed with different levels of complexity in their crown. The more primitive changes observed coincide with those which took place in animals of the Triassic period, some two hundred million years ago. The development of more posterior patterns corresponds with the different stages of evolution discovered in rodents that already became extinct in the Paleocene Epoch, approximately 60 million years ago. Researchers have therefore achieved the reproduction of the transitions observed in the fossil registry of mammal teeth.

The scientists were able to compare the shape of these teeth with a computer-generated prediction model created by Dr. Isaac Salazar-Ciudad, researcher at the Universitat Autònoma de Barcelona (UAB; Spain) and at the University of Helsinki, which reproduces how the tooth changes from a group of equal cells to a complicated three-dimensional (3D) structure, with the full shape of a molar tooth, computing the position of space of each cell. The model is capable of forecasting the changes in the morphology of the tooth when a gene is engineered, and therefore offers an explanation of the processes that cause these specific alterations to occur in the shape of teeth throughout evolution.

“Evolution has been explained as the ability of individuals to adapt to their environment in different ways,” Dr. Salazar-Ciudad stated, “But we do not know why or how individuals differ morphologically. The research helps to understand evolution, in each generation, as a game between the possible variations in form and natural selection.”

The research findings were published July 30, 2014, in the journal Nature.

Related Links:

Institute of Biotechnology of the University of Helsinki
Universitat Autònoma de Barcelona



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.